Delivery Order SPE2DB22D3016-SPE2DB25FBGX8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,458.39 to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 mg in 10ml vials, with a completion deadline of September 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 mg in 10ml vials, with an ultimate completion date of August 11, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428....
- The Defense Logistics Agency (DLA) awarded a $10,916.78 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of PHESGO 600-600 mg pharmaceutical product in 20,000 units of 10ml vials. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a non-competitive, non-set-aside award to support federal medical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The award was made on September 25, 2025, with an ultimate completion date of October 17, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of...
- The Defense Logistics Agency awarded a delivery order valued at $32,750.34 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of PHESGO 600-600 mg pharmaceutical product in 20,000 units of 10ml vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 26, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10ML vials, valued at $10,916.78, with a completion date of July 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 mg in 10ml vials, valued at $10,916.78. This is a firm fixed price delivery order with no set-aside designation, reflecting open competition. The award was executed on August 15, 2025, with a completion deadline of September 8, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,458.39 delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10ML vials. This delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, operates under a firm fixed-price contract type with no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for PHESGO 600-600 MG pharmaceutical products, with an order quantity of 20,000 units in 10ML vials. The contract is a firm fixed price delivery order with no set-aside designation, awarded on September 2, 2025, with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceutical products. The award, valued at $15,962.76, has an ultimate completion date of August 12, 2024. The contract is a Firm Fixed Price (FFP) delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of a larger Indefinite Delivery...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBGX8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10ML vials. This is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, issued on September 2, 2025. The contract utilizes no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. PHESGO is a combination biologic medication used in oncology treatment, and this delivery order represents a specific fulfillment of pharmaceutical supply needs for federal military and healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA contract vehicle demonstrates the company's established capability and prequalification to meet federal procurement requirements across multiple therapeutic domains, positioning it to serve customers including the Defense Health Agency and U.S. Coast Guard through a flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 9/2/25 |